Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial

References

• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metab Syndr Obes. 2018;11:533. doi:10.2147/DMSO.S146339
   PubMed Web of Science ®Google Scholar
• Yilmaz Y. Is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther. 2012;36(9):815–823. doi:10.1111/apt.12046
   PubMed Web of Science ®Google Scholar
• Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol. 2016;65(2):425–443. doi:10.1016/j.jhep.2016.04.005
   PubMed Web of Science ®Google Scholar
• Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–1253. doi:10.1053/j.gastro.2011.06.061
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Friedman SL, McCullough AJ, Dimick‐Santos L. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American association for the study of liver diseases–US food and drug administration joint workshop. Hepatology. 2015;61(4):1392–1405. doi:10.1002/hep.27678
   PubMed Web of Science ®Google Scholar
• Yu J, Marsh S, Hu J, Feng W, Wu C. The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background. Gastroenterol Res Pract. 2016;2016:1–13. doi:10.1155/2016/2862173
   Web of Science ®Google Scholar
• Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378. e365. doi:10.1053/j.gastro.2015.04.005
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhao M-G, Jiang C-H, et al. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. Phytomedicine. 2020;66:153130. doi:10.1016/j.phymed.2019.153130
   PubMedGoogle Scholar
• Gamede M, Mabuza L, Ngubane P, Khathi A. Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model. Diabetes Metab Syndr Obes. 2019;12:1953. doi:10.2147/DMSO.S218626
   PubMed Web of Science ®Google Scholar
• Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M. Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes. 2019;12:315. doi:10.2147/DMSO.S198744
   PubMed Web of Science ®Google Scholar
• Amagase H. Clarifying the real bioactive constituents of garlic. J Nutr. 2006;136(3):716S–725S. doi:10.1093/jn/136.3.716S
   PubMed Web of Science ®Google Scholar
• Kumar R, Chhatwal S, Arora S, et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes. 2013;6:49. doi:10.2147/DMSO.S38888
   PubMedGoogle Scholar
• Schwingshackl L, Missbach B, Hoffmann G. An umbrella review of garlic intake and risk of cardiovascular disease. Phytomedicine. 2016;23(11):1127–1133. doi:10.1016/j.phymed.2015.10.015
   PubMed Web of Science ®Google Scholar
• Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res. 2015;8(3):181–189. doi:10.1158/1940-6207.CAPR-14-0172
   PubMed Web of Science ®Google Scholar
• Lai Y-S, Chen W-C, Ho C-T, et al. Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress. J Agric Food Chem. 2014;62(25):5897–5906. doi:10.1021/jf500803c
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745–750. doi:10.1053/gast.2002.35354
   PubMed Web of Science ®Google Scholar
• Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr. 2004;23(5):1226–1243. doi:10.1016/j.clnu.2004.06.004
   PubMed Web of Science ®Google Scholar
• A’hern R. Sample size tables for exact single‐stage phase II designs. Stat Med. 2001;20(6):859–866. doi:10.1002/sim.721
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675–1685. doi:10.1056/NEJMoa0907929
   PubMed Web of Science ®Google Scholar
• Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829–846. doi:10.1016/j.jhep.2017.05.016
   PubMed Web of Science ®Google Scholar
• Seo DY, Lee SR, Kim HK, et al. Independent beneficial effects of aged garlic extract intake with regular exercise on cardiovascular risk in postmenopausal women. Nutr Res Pract. 2012;6(3):226–231. doi:10.4162/nrp.2012.6.3.226
   PubMedGoogle Scholar
• Lee M-S, Kim I-H, Kim C-T, Kim Y. Reduction of body weight by dietary garlic is associated with an increase in uncoupling protein mRNA expression and activation of AMP-activated protein kinase in diet-induced obese mice. J Nutr. 2011;141(11):1947–1953. doi:10.3945/jn.111.146050
   PubMedGoogle Scholar
• Kwak JS, Kim JY, Paek JE, et al. Garlic powder intake and cardiovascular risk factors: a meta-analysis of randomized controlled clinical trials. Nutr Res Pract. 2014;8(6):644–654. doi:10.4162/nrp.2014.8.6.644
   PubMed Web of Science ®Google Scholar
• Padiya R, Banerjee SK. Garlic as an anti-diabetic agent: recent progress and patent reviews. Recent Pat Food Nutr Agric. 2013;5(2):105–127. doi:10.2174/18761429113059990002
   PubMedGoogle Scholar
• Augusti K, Sheela C. Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia. 1996;52(2):115–119. doi:10.1007/BF01923354
   PubMedGoogle Scholar
• Younas J, Hussain F. In vitro antidiabetic evaluation of allium sativum L. In J Chem Biochem Sci. 2014;5:22–25.
   Google Scholar
• Ried K, Toben C, Fakler P. Effect of garlic on serum lipids: an updated meta-analysis. Nutr Rev. 2013;71(5):282–299. doi:10.1111/nure.12012
   PubMed Web of Science ®Google Scholar
• Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti‐hyperlipidemic agent. J Am Acad Nurse Pract. 2003;15(3):120–129. doi:10.1111/j.1745-7599.2003.tb00268.x
   PubMedGoogle Scholar
• Mader F. Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German association of general practitioners’ multicentric placebo-controlled double-blind study. Arzneimittel-Forschung. 1990;40(10):1111–1116.
   PubMedGoogle Scholar
• Chang MLW, Johnson MA. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr. 1980;110(5):931–936. doi:10.1093/jn/110.5.931
   PubMedGoogle Scholar
• Yeh -Y-Y, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr. 2001;131(3):989S–993S. doi:10.1093/jn/131.3.989S
   PubMed Web of Science ®Google Scholar
• Li C, Lun W, Zhao X, et al. Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells. Mediators Inflamm. 2015;2015:1–11. doi:10.1155/2015/434692
   Google Scholar
• Rahman MS. Allicin and other functional active components in garlic: health benefits and bioavailability. Int J Food Prop. 2007;10(2):245–268. doi:10.1080/10942910601113327
   Web of Science ®Google Scholar
• Kay HY, Won Yang J, Kim TH, et al. Ajoene, a stable garlic by-product, has an antioxidant effect through Nrf2-mediated glutamate-cysteine ligase induction in HepG2 cells and primary hepatocytes. J Nutr. 2010;140(7):1211–1219. doi:10.3945/jn.110.121277
   PubMedGoogle Scholar
• Panyod S, Wu W-K, Ho C-T, et al. Diet supplementation with allicin protects against alcoholic fatty liver disease in mice by improving anti-inflammation and antioxidative functions. J Agric Food Chem. 2016;64(38):7104–7113. doi:10.1021/acs.jafc.6b02763
   PubMed Web of Science ®Google Scholar
• Shi L, Lin Q, Li X, et al. Alliin, a garlic organosulfur compound, ameliorates gut inflammation through MAPK‐NF‐κB/AP‐1/STAT‐1 inactivation and PPAR‐γ activation. Mol Nutr Food Res. 2017;61(9):1601013. doi:10.1002/mnfr.201601013
   Web of Science ®Google Scholar
• Han CY, Ki SH, Kim YW, et al. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxid Redox Signal. 2011;14(2):187–202. doi:10.1089/ars.2010.3190
   PubMed Web of Science ®Google Scholar
• Masuzaki R, Tateishi R, Yoshida H, et al. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol Hepatol. 2008;22(9):753–757.
   Google Scholar